Voyager Therapeutics: 2Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Voyager Therapeutics Inc. (VYGR) on Friday reported second-quarter net income of $11.2 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Cambridge, Massachusetts-based company said it had net income of 29 cents.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 88 cents per share.
The gene therapy company posted revenue of $46.1 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $5.3 million.
Voyager Therapeutics shares have more than doubled since the beginning of the year. The stock has risen 21% in the last 12 months.